Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System

-
Investigator: Jeffrey W. Ralph, MD
Sponsor: MacroGenics, Inc.

Location(s): United States

Description

This study will test an experimental drug called MGAWN1 for the treatment of West Nile infections. The objective of this study is to provide expanded access to MGAWN1; the study is not intended for subjects who are eligible for and have access to non-expanded access protocols.